Your browser doesn't support javascript.
loading
Pembrolizumab monotherapy versus pembrolizumab plus chemotherapy in patients with non-small-cell lung cancer: A multicenter retrospective trial.
Matsumoto, Hiromi; Kobayashi, Nobuaki; Somekawa, Kohei; Fukuda, Nobuhiko; Kaneko, Ayami; Kamimaki, Chisato; Kubo, Sousuke; Tanaka, Katsushi; Tagami, Yoichi; Teranishi, Shuhei; Watanabe, Keisuke; Horita, Nobuyuki; Hara, Yu; Yamamoto, Masaki; Kudo, Makoto; Koizumi, Harumi; Miura, Kenji; Miyazawa, Naoki; Kaneko, Takeshi.
Afiliación
  • Matsumoto H; Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Kobayashi N; Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Somekawa K; Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Fukuda N; Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Kaneko A; Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Kamimaki C; Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Kubo S; Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Tanaka K; Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Tagami Y; Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Teranishi S; Respiratory Disease Center, Yokohama City University Medical Center, Yokohama, Japan.
  • Watanabe K; Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Horita N; Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Hara Y; Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Yamamoto M; Respiratory Disease Center, Yokohama City University Medical Center, Yokohama, Japan.
  • Kudo M; Respiratory Disease Center, Yokohama City University Medical Center, Yokohama, Japan.
  • Koizumi H; Department of Pulmonology, Yokohama Minami Kyosai Hospital, Yokohama, Japan.
  • Miura K; Respiratory Disease Center, Yokohama Sakae Kyosai Hospital, Yokohama, Japan.
  • Miyazawa N; Department of Pulmonology, Saiseikai Yokohamashi Nanbu Hospital, Yokohama, Japan.
  • Kaneko T; Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Thorac Cancer ; 13(2): 228-235, 2022 01.
Article en En | MEDLINE | ID: mdl-34866339
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pulmón de Células no Pequeñas / Anticuerpos Monoclonales Humanizados / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Thorac Cancer Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Singapur
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pulmón de Células no Pequeñas / Anticuerpos Monoclonales Humanizados / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Thorac Cancer Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Singapur